A transient MXD4-dependent proliferative pause enables survival of brain micrometastases.

A transient MXD4-dependent proliferative pause enables survival of brain micrometastases, with disruption reducing progression to macrometastases in models and patients.

• Why it matters: Understanding how metastasis-initiating cells survive early brain colonization addresses a critical gap in preventing metastatic relapse, especially after neurosurgical resection.
• What they did: Researchers identified a temporary proliferative arrest mediated by MXD4 in aggressive cancer cells during early brain colonization, validated this state in human micrometastases, and tested targeting strategies using patient-derived cultures and experimental models.
• The result: Targeting this proliferative pause with clinically available drugs may prevent brain metastasis progression and relapse, revealing new therapeutic opportunities to improve patient outcomes.